VALISONE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Valisone, and when can generic versions of Valisone launch?
Valisone is a drug marketed by Schering and is included in three NDAs.
The generic ingredient in VALISONE is betamethasone valerate. There are sixty-six drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the betamethasone valerate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Valisone
A generic version of VALISONE was approved as betamethasone valerate by FOUGERA PHARMS INC on August 31st, 1983.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for VALISONE?
- What are the global sales for VALISONE?
- What is Average Wholesale Price for VALISONE?
Summary for VALISONE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 64 |
| Patent Applications: | 5,113 |
| DailyMed Link: | VALISONE at DailyMed |
US Patents and Regulatory Information for VALISONE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Schering | VALISONE | betamethasone valerate | CREAM;TOPICAL | 016322-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Schering | VALISONE | betamethasone valerate | OINTMENT;TOPICAL | 016740-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Schering | VALISONE | betamethasone valerate | CREAM;TOPICAL | 016322-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
